| Literature DB >> 30105123 |
Gregory Costain1,2, Michal Inbar-Feigenberg2, Maha Saleh1,2, Shimrit Yaniv-Salem3, Greg Ryan3, Eric Morgen4, Elaine S Goh5, Gen Nishimura6, David Chitayat2,7.
Abstract
Traditional approaches to prenatal genetic diagnosis for common presentations such as short femurs or intrauterine growth restriction are imperfect, and whole-exome sequencing is an emerging option. Mucolipidosis type II (I-cell disease) is an ultra-rare autosomal recessive lysosomal storage disorder with the potential for prenatal-onset skeletal and placental manifestations. We describe the prenatal signs in two recent unrelated patients with confirmed diagnoses soon after birth. In both cases, parents were consanguineous but there was no known family history of mucolipidosis type II. False reassurance was provided after negative testing for another disease with overlapping prenatal manifestations already present in one of the families, emphasizing that offspring of consanguineous parents can be at risk for more than one recessive condition. Our experience illustrates the potential advantages in expanding prenatal applications of WES for the identification of rare single gene disorders in offspring of consanguineous unions.Entities:
Keywords: genetic testing; lysosomal storage disease; mucolipidosis; prenatal diagnosis; skeletal dysplasia
Year: 2018 PMID: 30105123 PMCID: PMC6087473 DOI: 10.1055/s-0038-1636995
Source DB: PubMed Journal: J Pediatr Genet ISSN: 2146-460X